Document Detail

Rifampicin - A mild immunosuppressive agent for psoriasis.
MedLine Citation:
PMID:  20653488     Owner:  NLM     Status:  In-Data-Review    
Abstract The immunosuppressive properties of rifampicin have been discussed in the literature for more than 30 years. It is hypothesized that rifampicin acts as a mild immunosuppressive agent in psoriasis rather than an antibacterial one. We report our studies on the therapeutic efficacy of rifampicin in guttate psoriasis. We try to give light on the mechanism of action of rifampicin in psoriasis. Our therapeutic results together with data from the literature revealed rifampicin to be a mild immunosuppressive agent. Its best effectiveness is in the guttate type of the disease.
Nikolai Tsankov; Ivan Grozdev
Related Documents :
1923078 - Antibiotic treatment of otitis media with effusion.
25441328 - Identifying errors and inconsistencies in real time while using facilitated echocardiog...
20205798 - An alternative treatment of hyperlipidemia with red yeast rice: a case report.
17649318 - Diethylstilbesterol as a contaminant in mink feeding.
22871108 - Granulomatous interstitial nephritis in a patient with crohn's disease.
3480068 - Exposure to hair dyes and polychlorinated dibenzo-p-dioxins in aids patients with kapos...
Publication Detail:
Type:  Journal Article     Date:  2010-07-24
Journal Detail:
Title:  The Journal of dermatological treatment     Volume:  22     ISSN:  1471-1753     ISO Abbreviation:  J Dermatolog Treat     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8918133     Medline TA:  J Dermatolog Treat     Country:  England    
Other Details:
Languages:  eng     Pagination:  62-4     Citation Subset:  IM    
Department of Dermatology and Venereology, Medical Faculty - Sofia, Bulgaria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis.
Next Document:  Appropriateness of early management of newly diagnosed Crohn's disease in a European population-base...